TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Dr. Dyrevenn AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
849
|
802
|
856 |
| Financial expenses |
1
|
1
|
0 |
| Earnings before taxes |
464
|
423
|
486 |
| Total assets |
2,550
|
2,250
|
2,035 |
| Current assets |
2,207
|
2,073
|
1,808 |
| Current liabilities |
209
|
165
|
161 |
| Equity capital |
2,341
|
2,085
|
1,874 |
| - share capital |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.8%
|
92.7%
|
92.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
54.7%
|
52.7%
|
56.8% |
| Return on assets (ROA) |
18.2%
|
18.8%
|
23.9% |
| Current ratio |
1056.0%
|
1256.4%
|
1123.0% |
| Return on equity (ROE) |
19.8%
|
20.3%
|
25.9% |
| Change turnover |
88
|
1
|
213 |
| Change turnover % |
12%
|
0%
|
33% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.